(MedPage Today) -- CHICAGO -- Treatment of giant cell arteritis (GCA) with the oral drug upadacitinib (Rinvoq) was durably effective when continued for 2 years, results from a phase III...

(MedPage Today) -- "If that doesn't blow your mind." -- Christine Lovly, MD, PhD, of the Vanderbilt-Ingram Cancer Center in Nashville, discussing studies that emphasized the improvement in lung cancer...

(MedPage Today) -- ORLANDO -- Postmenopausal women using hormone therapy (HT) saw significantly greater weight loss while taking the dual GIP/GLP-1 receptor agonist tirzepatide than their counterparts not using HT,...

BBCThe government will not "be held to ransom" by striking doctors, Health Secretary Wes Streeting has said.A five-day walkout by resident doctors is due to take place between 14-19 November,...

(MedPage Today) -- In healthcare, prevention is too often treated as optional -- an add-on when budgets allow. But prevention isn't a luxury. It is the most economically sound, clinically...

(MedPage Today) -- ORLANDO -- A non-hormonal treatment for menopausal moderate-to-severe vasomotor symptoms that just nabbed FDA approval was safe and well-tolerated up to 1 year of treatment, according to...

(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz Source link : https://www.medpagetoday.com/quizzes/news-quiz/118140 Author : Publish date : 2025-10-25 21:00:00 Copyright for syndicated...

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president...

(MedPage Today) -- Last month, federal health authorities and President Trump publicized an unsubstantiated claim suggesting that acetaminophen use by pregnant women is associated with the development of autism in...

(MedPage Today) -- ATLANTA -- Oral tebipenem pivoxil (TBP-PI) was non-inferior to IV imipenem-cilastatin (IMI-CIL) for treating complicated urinary tract infections (cUTI), including acute pyelonephritis (AP), according to a phase...

(MedPage Today) -- Two advisers to HHS Secretary Robert F. Kennedy Jr. sat on a stage in California this spring, addressing an audience at a natural products industry trade show...

Parents are being urged to get their children vaccinated against flu over half-term as the NHS warned of rising cases of the disease.There is an early flu season, health officials...

(MedPage Today) -- Having an automatic external defibrillator (AED) in a private home does appear to increase the likelihood of survival in people who experience certain types of cardiac arrest,...

Share on PinterestNew research identified a 27% increased risk of metabolic syndrome among subjects experiencing early natural menopause. Nazar Rybak/Getty ImagesA study has found that early menopause is linked with...

Available for over a yearFormer England ruby captain Lewis Moody recently revealed he had been diagnosed with Motor Neurone Disease (MND), and our conversations give an insight into how lives...

Ruth CleggHealth and wellbeing reporterGetty ImagesIt's been described as the mineral of the moment.Millions of us are taking magnesium for a whole range of reasons. Can it help us sleep...

(MedPage Today) -- Surgery without chemotherapy or radiation offers a potential cure for some patients with pancreatic cancer -- but with a catch, a retrospective cohort study suggested. Patients who...

BCG failure is much less common than previously thought in non-muscle invasive bladder cancer, so is adding a checkpoint inhibitor worth it? Medscape Medical News Source link : https://www.medscape.com/viewarticle/immune-checkpoint-add-ons-bcg-no-slam-dunk-2025a1000t36?src=rss Author...

Both age for women and sex are related to the likelihood of having chronic rhinosinusitis with polyps. Medscape Medical News Source link : https://www.medscape.com/viewarticle/does-biological-sex-influence-chronic-rhinosinusitis-2025a1000t32?src=rss Author : Publish date : 2025-10-24...

(MedPage Today) -- The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer announced on Friday. Elinzanetant is now the first and...